Patient Factors That Influence How Physicians Discuss Active Surveillance With Low-Risk Prostate Cancer Patients: A Qualitative Study
- PMID: 29973123
- PMCID: PMC6142114
- DOI: 10.1177/1557988318785741
Patient Factors That Influence How Physicians Discuss Active Surveillance With Low-Risk Prostate Cancer Patients: A Qualitative Study
Abstract
For men diagnosed with prostate cancer, making treatment decisions can be overwhelming. Navigating treatment options, along with potential treatment side effects, can be difficult, and patients often rely heavily on the advice of their physicians. This study was aimed at understanding more about the way urologists talk with their patients about one treatment option: active surveillance (AS), a recognized management strategy for men with low-risk prostate cancer that includes close observation and monitoring of the cancer. This study reports, through 22 interviews with urologists, that urologists believe patients are hesitant about AS for a number of reasons, including misperceptions about cancer severity, anxiety, aversion to repeated biopsies that accompany AS, or family member preferences. Because urologists play an influential role in educating patients about treatment options, the discussion around AS can be impacted by barriers that physicians believe matter for their patients. Improving awareness among urologists about what factors impact their patient education about low-risk prostate cancer is important. Identifying tools to improve shared decision making in this area could result in treatment decisions that are increasingly concordant with patients' values, concerns, and goals.
Keywords: active surveillance; low-risk prostate cancer; physician–patient communication; prostate cancer treatment.
Conflict of interest statement
Similar articles
-
Physician Recommendations Trump Patient Preferences in Prostate Cancer Treatment Decisions.Med Decis Making. 2017 Jan;37(1):56-69. doi: 10.1177/0272989X16662841. Epub 2016 Aug 10. Med Decis Making. 2017. PMID: 27510740 Free PMC article.
-
Selecting men diagnosed with prostate cancer for active surveillance using a risk calculator: a prospective impact study.BJU Int. 2012 Jul;110(2):180-7. doi: 10.1111/j.1464-410X.2011.10679.x. Epub 2011 Nov 23. BJU Int. 2012. PMID: 22112199
-
Active surveillance of prostate cancer: a questionnaire survey of urologists, clinical oncologists and urology nurse specialists across three cancer networks in the United Kingdom.BMC Urol. 2015 Jun 13;15:52. doi: 10.1186/s12894-015-0049-y. BMC Urol. 2015. PMID: 26070313 Free PMC article.
-
Patient and disease factors affecting the choice and adherence to active surveillance.Curr Opin Urol. 2015 May;25(3):272-6. doi: 10.1097/MOU.0000000000000154. Curr Opin Urol. 2015. PMID: 25692724 Review.
-
Active surveillance of prostate cancer in African American men.Urology. 2014 Dec;84(6):1255-61. doi: 10.1016/j.urology.2014.06.064. Epub 2014 Oct 3. Urology. 2014. PMID: 25283702 Review.
Cited by
-
Social ecological influences on treatment decision-making in men diagnosed with low risk, localised prostate cancer.Eur J Cancer Care (Engl). 2022 Nov;31(6):e13697. doi: 10.1111/ecc.13697. Epub 2022 Sep 22. Eur J Cancer Care (Engl). 2022. PMID: 36138320 Free PMC article.
-
Patient Preferences and Treatment Decisions for Prostate Cancer: Results From A Statewide Urological Quality Improvement Collaborative.Urology. 2021 Sep;155:55-61. doi: 10.1016/j.urology.2021.04.020. Epub 2021 Apr 29. Urology. 2021. PMID: 33933504 Free PMC article.
-
Perceived barriers to the adoption of active surveillance in low-risk prostate cancer: a qualitative analysis of community and academic urologists.BMC Cancer. 2021 May 31;21(1):649. doi: 10.1186/s12885-021-08386-3. BMC Cancer. 2021. PMID: 34058998 Free PMC article.
-
Preferred labels and language to improve communication about lesions at low risk of progressing to cancer: qualitative interviews with patients and physicians.BMJ Open. 2025 Jan 2;15(1):e087484. doi: 10.1136/bmjopen-2024-087484. BMJ Open. 2025. PMID: 39753257 Free PMC article.
-
Development, acceptability, appropriateness and appeal of a cancer clinical trials implementation intervention for rural- and minority-serving urology practices.Trials. 2019 Oct 7;20(1):578. doi: 10.1186/s13063-019-3658-z. Trials. 2019. PMID: 31590694 Free PMC article. Review.
References
-
- Andersen R. M. (1995). Revisiting the behavioral model and access to medical care: Does it matter? Journal of Health and Social Behavior, 36(1), 1–10. - PubMed
-
- Bahnson R. R., Hanks G. E., Huben R. P., Kantoff P., Kozlowski J. M., Kuettel M. … National Comprehensive Cancer Network. (2000). NCCN practice guidelines for prostate cancer. Oncology (Williston Park, N.Y.), 14(11A), 111–119. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials